SCHEMBL9953653

SCHEMBL9953653

O=c1c2cc(I)ccc2[nH]c(=S)n1-c1ccccc1C(F)(F)F

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 4/20 0.51
CA1 P00915 4/20 0.51
CA2 P00918 4/20 0.51
CA9 Q16790 3/20 0.51
KDM4E B2RXH2 4/20 0.49
MAPT P10636 3/20 0.49
ALDH1A1 P00352 4/20 0.45
L3MBTL1 Q9Y468 2/20 0.45
RXFP1 Q9HBX9 2/20 0.45
PDE7A Q13946 2/20 0.44
SMN1; SMN2 Q16637 3/20 0.43
ALOX12 P18054 2/20 0.42
NPSR1 Q6W5P4 2/20 0.42
KMT2A Q03164 2/20 0.42
MEN1 O00255 1/20 0.42
HPGD P15428 1/20 0.42
PDE7B Q9NP56 1/20 0.42
HTT P42858 3/20 0.42
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9952831 0.85 KDM4E (0.58) CA12CA1CA2CA9KDM4E
SCHEMBL9954263 0.83 CA12 (0.48) CA12CA1CA2CA9KDM4E
SCHEMBL9954771 0.81 KDM4E (0.54) CA12CA1CA2CA9KDM4E
SCHEMBL9954834 0.81 CA12 (0.57) CA12CA1CA2CA9KDM4E
SCHEMBL9952534 0.81 CA12 (0.56) CA12CA1CA2CA9KDM4E
SCHEMBL9955263 0.80 KMT2A (0.60) CA12CA1CA2CA9KDM4E
SCHEMBL9952357 0.80 CA12 (0.57) CA12CA1CA2CA9KDM4E
SCHEMBL9954144 0.78 ALDH1A1 (0.71) CA12CA1CA2CA9KDM4E
SCHEMBL10288889 0.78 CA12 (0.65) CA12CA1CA2CA9ALDH1A1
SCHEMBL9953692 0.78 CA12 (0.64) CA12CA1CA2CA9ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012087938-A1 QUINAZOLINONE DERIVATIVES AS ANTIVIRAL AGENTS GLAXOSMITHKLINE LLC (US) 2012-06-28 WO disclosed
WO-2012087938-A1 QUINAZOLINONE DERIVATIVES AS ANTIVIRAL AGENTS GLAXOSMITHKLINE LLC (US) 2012-06-28 WO disclosed